Eric Warren, Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS), sold 104,124 shares at $25.90 ($2.7M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($2.7M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MLYS | SELL | 2026-07-23 | $200K | — | Filing → |
| ESPR | SELL | 2025-04-21 | $106 | — | Filing → |
| ESPR | SELL | 2025-03-19 | $4K | — | Filing → |